The MTL-005 programme has a robust intellectual property position. It is based on extensive, international patent applications comprising both composition-of-matter and methods-of-use claims. The base patent has been granted in the US and is in final filings in Europe. Methods-of-use and formulations patents have also been filed for international coverage and are currently under review. There should be international coverage on MTL-005 until at least mid 2030.